Promising Enzymes for Inhibitors Development Against COVID-19.

After the emergence of COVID-19 in 2019, it has now become a pandemic. COVID-19 has brought painful disasters to people all over the world. It not only threatens lives and health but also induces economic crises.

Identification of an immune-related gene-based signature to predict prognosis of patients with gastric cancer.

Background: Gastric cancer (GC) is the most commonly diagnosed malignancy worldwide. Increasing evidence suggests that it is necessary to further explore genetic and immunological characteristics of GC.

Aim: To construct an immune-related gene (IRG) signature for accurately predicting the prognosis of patients with GC.